| Dec'17 | ||||||
|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||
Net loss | ||||||
-18,173 | ||||||
Adjustments: | ||||||
Depreciation and amortization | ||||||
1,361 | ||||||
Revaluation of controlling shareholders loans | ||||||
0 | ||||||
Revaluation of liability in respect of government grants | ||||||
-105 | ||||||
Revaluation of derivative instruments | ||||||
0 | ||||||
Financing expenses (income) | ||||||
-922 | ||||||
Loss from disposal and sale of fixed assets | ||||||
-84 | ||||||
Share-based payments | ||||||
1,821 | ||||||
Profit loss | ||||||
4,083 | ||||||
Changes in assets and liabilities: | ||||||
Increase in inventory | ||||||
-2,315 | ||||||
Increase in other receivables | ||||||
209 | ||||||
Decrease (increase) in trade receivables | ||||||
-51 | ||||||
Increase in other payables | ||||||
102 | ||||||
Increase in trade payables | ||||||
-201 | ||||||
Decrease in other long term liabilities | ||||||
-62 | ||||||
Changes in assets and liabilities | ||||||
-2,318 | ||||||
Net cash used in operating activities | ||||||
-16,408 | ||||||
Cash flow from investing activities | ||||||
Decrease (increase) in restricted bank deposits | ||||||
-186 | ||||||
Acquisition of property plant and equipment | ||||||
3,648 | ||||||
Proceeds from sale of fixed assets | ||||||
-2 | ||||||
Net cash used in investing activities | ||||||
-3,832 | ||||||
Cash flow from financing activities: | ||||||
Proceeds from issuance of ordinary shares and warrants, net | ||||||
12,757 | ||||||
Exercise of warrants and options | ||||||
318 | ||||||
Amounts recognized in respect of government grants liability, net | ||||||
461 | ||||||
Payment of controlling shareholder loans | ||||||
0 | ||||||
Net cash provided by financing activities | ||||||
13,536 | ||||||
Increase in cash and cash equivalents | ||||||
-6,704 | ||||||
Effect of exchange rate fluctuations on cash | ||||||
-922 | ||||||
Non-cash transactions: | ||||||
Property plant and equipment acquired on credit | ||||||
251 | ||||||